Aminoguanidine impedes human pancreatic tumor growth and metastasis development in nude mice

World Journal of Gastroenterology

Volumn 15, Issue 9, 2009, Pages 1065-1071

  Mohamad, Nora A ^a   Criocco, Graciela P ^a   Sambuco, Lorena A ^a   Croci, Máximo ^b   Medina, Vanina A ^a   Gutiérrez, Alicia S ^a   Bergoc, Rosa M ^a,c   Rivera, Elena S ^a   Martín, Gabriela A ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Institute of Immunooncology Dr Ernesto Crescenti   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Aminoguanidine; Apoptosis; Metastasis; Pancreatic ductal carcinoma; Tumor growth

Indexed keywords

AMINOGUANIDINE; CATALASE; CD34 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; KI 67 ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; SUPEROXIDE DISMUTASE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS INHIBITION; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PANCREAS TUMOR; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SYNTHESIS INHIBITION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; VASCULARIZATION; ANIMAL; CANCER TRANSPLANTATION; CELL DIVISION; DRUG EFFECT; ENZYMOLOGY; GENETICS; METASTASIS; METHODOLOGY; PATHOLOGY; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; CELL DIVISION; ENZYME INHIBITORS; GLUTATHIONE PEROXIDASE; GUANIDINES; HUMANS; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NITRIC OXIDE SYNTHASE TYPE III; PANCREATIC NEOPLASMS; SUPEROXIDE DISMUTASE; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65549126881     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1065     Document Type: Article

References (35)

1. Rosenberg L. Pancreatic cancer: a review of emerging therapies. Drugs 2000; 59: 1071-1089
2. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 2004; 279: 36167-36170
3. Fulton D, Fontana J, Sowa G, Gratton JP, Lin M, Li KX, Michell B, Kemp BE, Rodman D, Sessa WC. Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J Biol Chem 2002; 277: 4277-4284
4. Kim PK, Zamora R, Petrosko P, Billiar TR. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001; 1: 1421-1441
5. Lechner M, Lirk P, Rieder J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 2005; 15: 277-289
6. Fukumura D, Jain RK. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 1998; 17: 77-89
7. Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 1998; 17: 91-106
8. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125
9. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221-232
10. Corman B, Duriez M, Poitevin P, Heudes D, Bruneval P, Tedgui A, Levy BI. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci USA 1998; 95: 1301-1306
11. Nam KT, Kim DY, Park MS, Jang DD, Yang KH, Han JH, Yoon BI. Suppression of cholangiocarcinoma development by aminoguanidine in the liver fluke-infested hamster. J Toxicol Pathol 2005; 18: 65-68
12. Wang GY, Ji B, Wang X, Gu JH. Anti-cancer effect of iNOS inhibitor and its correlation with angiogenesis in gastric cancer. World J Gastroenterol 2005; 11: 3830-3833
13. Nilsson BO. Biological effects of aminoguanidine: an update. Inflamm Res 1999; 48: 509-515
14. Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys 2003; 419: 31-40
15. Cricco G, Medina V, Núñez M, Mohamad N, Gutiérrez A, Bergoc R, Rivera E, Martín G. Nitric oxide involvement in histamine-mediated PANC-1 cells growth. Inflamm Res 2007; 56 Suppl 1: S39-S40
16. Muskhelishvili L, Latendresse JR, Kodell RL, Henderson EB. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. J Histochem Cytochem 2003; 51: 1681-1688
17. Ridnour LA, Thomas DD, Donzelli S, Espey MG, Roberts DD, Wink DA, Isenberg JS. The biphasic nature of nitric oxide responses in tumor biology. Antioxid Redox Signal 2006; 8: 1329-1337
18. Gupta MK, Qin RY. Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol 2003; 9: 1144-1155
19. Kinnula VL, Crapo JD. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 2004; 36: 718-744
20. Okada F, Tazawa H, Kobayashi T, Kobayashi M, Hosokawa M. Involvement of reactive nitrogen oxides for acquisition of metastatic properties of benign tumors in a model of inflammation-based tumor progression. Nitric Oxide 2006; 14: 122-129
21. Williams EL, Djamgoz MB. Nitric oxide and metastatic cell behaviour. Bioessays 2005; 27: 1228-1238
22. Baserga R. The contradictions of the insulin-like growth factor 1 receptor. Oncogene 2000; 19: 5574-5581
23. Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 2001; 61: 318-326
24. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Muroni MR, Simile MM, Frau M, Tomasi ML, De Miglio MR, Seddaiu MA, Daino L, Sanna V, Feo F, Pascale RM. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease. Carcinogenesis 2008; 29: 1639-1647
25. Cricco G, Martín G, Medina V, Núñez M, Gutiérrez A, Cocca C, Bergoc R, Rivera E. Histamine regulates the MAPK pathway via the H(2) receptor in PANC-1 human cells. Inflamm Res 2004; 53 Suppl 1: S65-S66
26. Müerköster S, Wegehenkel K, Arlt A, Witt M, Sipos B, Kruse ML, Sebens T, Klöppel G, Kalthoff H, Fölsch UR, Schäfer H. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 2004; 64: 1331-1337
27. Tse GM, Wong FC, Tsang AK, Lee CS, Lui PC, Lo AW, Law BK, Scolyer RA, Karim RZ, Putti TC. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour. J Clin Pathol 2005; 58: 600-604
28. Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003; 50: 49-59
29. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W. Effect of aminoguanidine on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes. Clin Chem Lab Med 1998; 36: 771-775
30. Abd El-Gawad HM, El-Sawalhi MM. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine. J Biochem Mol Toxicol 2004; 18: 69-77
31. Díez-Fernández C, Sanz N, Alvarez AM, Zaragoza A, Cascales M. Influence of aminoguanidine on parameters of liver injury and regeneration induced in rats by a necrogenic dose of thioacetamide. Br J Pharmacol 1998; 125: 102-108
32. Yildiz G, Demiryürek AT, Sahin-Erdemli I, Kanzik I. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 1998; 124: 905-910
33. Noda T, Iwakiri R, Fujimoto K, Aw TY. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. FASEB J 2001; 15: 2131-2139
34. Menon SG, Goswami PC. A redox cycle within the cell cycle: ring in the old with the new. Oncogene 2007; 26: 1101-1109
35. Aw TY. Cellular redox: a modulator of intestinal epithelial cell proliferation. News Physiol Sci 2003; 18: 201-204